A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer
Clinical trial NCT03703466 · COMPLETED
Trial details
- NCT number
- NCT03703466
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-28
- Primary completion
- 2019-07-29
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.